Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 4/2010

01-04-2010 | Letter

Is laparoscopic gastrectomy safe for western patients with gastric cancer with high body mass index?

Authors: D. Kanellos, I. Kanellos

Published in: Surgical Endoscopy | Issue 4/2010

Login to get access

Excerpt

During the last decade, clinical outcomes of patients with gastric cancer have improved [1, 2]. Both survival and quality of life (QOL) of patients with adenocarcinoma of the stomach can be improved with appropriate treatment [3]. Although disease-free and overall survival have been improved due to standardized D2 gastrectomy [4‐11] plus preoperative (neoadjuvant) or postoperative chemotherapy alone or plus radiotherapy [12‐14], this improvement for patients with advanced potentially curable stage II and III disease is modest. Adjuvant molecularly targeting therapy for gastric cancer is still considered experimental and despite current limitations, there is hope that the next generation targeted agents will further prolong survival and cure rates for patients with solid cancers, including gastric cancer [15]. …
Literature
1.
Kappas AM et al (2002) Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol 9(9):828–830CrossRefPubMed
2.
Roukos DH (2009) Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol 16(4):795–798CrossRefPubMed
3.
Liakakos T et al (2008) More controversy than ever: challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol 15(4):956–960CrossRefPubMed
4.
Roukos DH, Paraschou P, Lorenz M (2000) Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7(10):719–726CrossRefPubMed
5.
Roukos DH, Kappas AM (2002) Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 81:59–62CrossRefPubMed
6.
Kappas AM et al (2004) Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11:727–730CrossRefPubMed
7.
Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250(2):349–350CrossRefPubMed
8.
Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22(6):1553–1555CrossRefPubMed
9.
Roukos DH, Hottenrott C, Lorenz M, Koutsogiorgas-Couchell S (1990) A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach. An analysis of early results and long-term survival. J Cancer Res Clin Oncol 116:307–311CrossRefPubMed
10.
Roukos DH, Hottenrott C, Encke A, Baltogiannis G, Casioumis D (1994) Primary gastric lymphomas: a clinicopathologic study with literature review. Surg Oncol 3(2):115–125CrossRefPubMed
11.
Roukos DH (2004) Early-stage gastric cancer: a highly treatable disease. Ann Surg Oncol 11:127–129CrossRefPubMed
12.
Briasoulis E, Fatouros M et al (2007) Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14:2691–2695PubMedCrossRef
13.
Roukos DH (2002) Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9:220–221CrossRefPubMed
14.
Briasoulis E, Liakakos T, Dova L et al (2006) Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer. Expert Rev Anticancer Ther 6:931–939CrossRefPubMed
15.
Roukos DH (2009) Mea culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev Mol Diagn 9(3):217–221CrossRefPubMed
16.
Strong VE, Devaud N, Allen PJ et al (2009) Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol 16(6):1507–1513CrossRefPubMed
17.
Lee HJ, Kim HH, Kim MC et al (2009) The impact of a high body mass index on laparoscopy assisted gastrectomy for gastric cancer. Surg Endosc Apr 3 [Epub ahead of print]
18.
Roukos DH (2009) Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn 9(1):1–6CrossRefPubMed
19.
Roukos DH (2009) Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol 16(3):772–773CrossRefPubMed
20.
Roukos DH, Ziogas D (2009) Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the “Gordian Knot”? Ann Surg Oncol 16(3):774–775CrossRefPubMed
21.
Ziogas D, Baltogiannis G, Fatouros M et al (2008) Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg 247(4):714–715CrossRefPubMed
22.
23.
Roukos DH (2009) Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer. J Clin Oncol 27(8):1337–1338CrossRefPubMed
24.
Roukos DH (2008) Breast-cancer stromal cells with TP53 mutations. N Engl J Med 358(15):1636PubMed
25.
Fatouros M et al (2008) The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol 15(1):21–33CrossRefPubMed
26.
Fatouros M et al (2005) Factors increasing local recurrence in breast-conserving surgery. Expert Rev Anticancer Ther 5(4):737–745CrossRefPubMed
27.
Roukos DH (2007) Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357(2):1555–1556PubMed
28.
Roukos DH (2009) Genome-wide association studies: how predictable is a person’s cancer risk? Expert Rev Anticancer Ther 9(4):389–392CrossRefPubMed
29.
Roukos DH (2009) Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn 9(3):227–229CrossRefPubMed
30.
Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249(6):1067–1068CrossRefPubMed
31.
Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16(7):1771–1782CrossRefPubMed
Metadata
Title
Is laparoscopic gastrectomy safe for western patients with gastric cancer with high body mass index?
Authors
D. Kanellos
I. Kanellos
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 4/2010
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-009-0696-8

Other articles of this Issue 4/2010

Surgical Endoscopy 4/2010 Go to the issue

OriginalPaper

Laparoscopy or laparotomy? A comparison of 240 patients with early-stage endometrial cancer

White Paper

Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) statement on the relationship between professional medical associations and industry

OriginalPaper

Flavored anesthetic lozenge versus Xylocaine spray used as topical pharyngeal anesthesia for unsedated esophagogastroduodenoscopy: a randomized placebo-controlled trial

OriginalPaper

Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population

OriginalPaper

Treatment of ultralong-segment Barrett’s using focal and balloon-based radiofrequency ablation

Letter

Thoracoscopic robot-assisted extended thymectomy in the human cadaver